Table 2 Characteristics of study population.
From: Serum HDL subfractions are impaired by COVID-19 vaccine in patients with thymic epithelial tumors
TET patients (n = 45) | Subgroup 1 (n = 24) | Subgroup 2 (n = 21) | |
|---|---|---|---|
Age (years) | 55.0 (47.5–64.0) | 54.5 (47.0–64.0) | 55.0 (46.5–64.0) |
Male, n (%) | 17 (38) | 9 (38) | 8 (38) |
BMI | 25.8 (23–32.5) | 26.4 (23.3–33.6) | 25 (20.5–31.1) |
Diabetes, n (%) | 11 (24) | 6 (25) | 5 (24) |
Smoker, n (%) | 15 (33) | 8 (33) | 7 (33) |
Dyslipidemia, n (%) | 11 (24) | 5 (21) | 6 (29) |
Statins, n (%) | 7 (16) | 3 (13) | 4 (19) |
Beta-blockers, n (%) | 18 (40) | 12 (50) | 6 (29) |
Treatment, n (%) * | 21 (47) | 12 (50) | 9 (43) |
Autoimmune diseases, n (%) | 17 (38) | 9 (38) | 8 (38) |
Miastenia gravis (MG), n (%) | 8 (18) | 4 (17) | 4 (19) |
Severe immunodeficiency, n (%) | 24 (53) | 13 (54) | 11 (52) |
